NPHLA Daily
NPHLA Daily
Monday, October 12, 2026 · 4-minute read
Good morning. Here is what changed across metabolic medicine, pharmacy regulation, aesthetics and healthcare technology since yesterday — every item linked to its source.
Top development today
What changed today in Metabolic: 1 new study
NPHLA tracked 1 new official record on this desk today: 1 new study. First: New research in Clinics in dermatology: “"Ozempic Face" and Facial Aging”.
Metabolic signal
"Ozempic Face" and Facial Aging
From Clinics in dermatology.
Regulatory signal
What changed today in Regulatory: 1 new study
NPHLA tracked 1 new official record on this desk today: 1 new study. First: New research in Hospital pharmacy: “Operational Workflows and Decision Making Processes in Hospital Pharmacy Services During Drug Shortages: A Scoping Review”.
One thing worth watching
Comments close: Agency Information Collection Activities; Proposed Collection; Comment Request; Registration of Human Drug Compounding Outsourcing Facilities Under the Federal Food, Drug, and…
October 29, 2026 — verified from the Federal Register comments_close_on.
5 things to know
Compiled by NPHLA Intelligence from published briefings and official records. Professional information only — not medical or legal advice. Our standards.